Loss of IL-27 signaling, as observed in IL-27Rα-deficient models, exacerbates tubulointerstitial fibrosis and enhances Th17-mediated inflammatory responses, highlighting its potential inhibitory role in renal hypertension (20) (Figure 2). Here, IL27 is linked to renal hypertension.